Blog

Where’s Waldo? Identifying KOLs to Make an Impact

Posted by: Lynn Clement on 4/17/2019

In the healthcare industry, we’re privileged to work alongside some of the brightest and most driven individuals in the world. The top voices in a medical field function as a trusted source of information to their peers as well as to those bringing new medical interventions to market.


Read Full Post

Tags: Key Opinion Leaders | Market Research | KJT Group
Related Posts: Winter 2019

Insights from Psychology: Simple Symbols Can Influence Evaluations

Posted by: Julie Maier on 4/15/2019

When it comes to capturing honest, representative information from respondents about their attitudes, their behaviors, and their feelings, even the smallest of things can risk skewing the results. 


Read Full Post

Tags: KJT Group | Survey Research | Psychology

Rare Diseases Require Rare Recruiting Methods

Posted by: Ty Lantz-Subtelny on 4/11/2019

Research among patients is vital to closing the information asymmetry between drug producers and end users. For many diseases, finding patients willing to share their experiences is no issue at all. However, conducting research among rare disease patients is a unique challenge due to, you guessed it, the rarity of their disease.


Read Full Post

Tags: Rare Disease | Patient Research | Recruiting
Related Posts: Rare Diseases Require Rare Recruiting Methods

Quantitative Research for Small Markets and Samples

Posted by: Christopher Claeys on 3/28/2019

During our 2017 webinar “Research for Small Markets and Samples” I made the point that small market business objectives addressed via central tendency measures are less helpful – I would like to revisit and challenge this.


Read Full Post

Tags: Rare Disease | Central Tendency | Small Samples
Related Posts: Quantitative Research for Small Markets and Samples

Anecdotes versus Evidence: Validating the Diagnosis Process

Posted by: Michaela Gascon and Jessica Spilman on 3/14/2019

How long does it take to ascertain the correct diagnosis? Which doctors will patients see, and who will they be referred to next? These seemingly direct questions are often all too complicated in rare disease. If we could better educate providers about disease symptoms and triggers, perhaps patients could be diagnosed sooner, and begin appropriate treatment sooner as well. That’s exactly what the International Pemphigoid and Pemphigus Foundation (IPPF) had in mind. Read the full post to learn how we helped!


Read Full Post

Tags: Patient Journey | Rare Disease | Orphan Disease
Related Posts: Winter 2019

What is Patient Journey?

Posted by: Amy Allen and Michelle Soto on 2/28/2019

What is patient journey? There is often overlap and sometimes interchangeable terminology among patient journey, patient flow through the healthcare system, and the treatment buying process. In rare diseases, the patient journey can be even more critical, as there may be a lack of internal knowledge, published data, or even currently available treatments. Read the full post to learn more!


Read Full Post

Tags: Patient Journey | Rare Disease | Orphan Disease
Related Posts: Winter 2019